Navigation Links
Oncobiologics and inVentiv Health Form Strategic Partnership around Biosimilars
Date:8/6/2013

CRANBURY, N.J., Aug. 6, 2013 /PRNewswire/ -- Oncobiologics, Inc. and inVentiv Health today announced a broad strategic partnership around clinical development for all assets in Oncobiologic's pipeline.  The scope of the partnership is global and will initially focus on biosimilar assets, and could be expanded to include innovative molecules.  Through the partnership, inVentiv Health will provide leadership and execution for clinical studies, as well as the corresponding bioanalytical support for those trials.  As the assets are commercialized, the partnership will be broadened to include inVentiv's significant commercialization capabilities in select countries.  This will position Oncobiologics attractively in seeking future commercial partners.

The current biosimilar assets include generic versions of Humira®, Rituxan®, Avastin®, Herceptin® and Erbitux®. These biologics are the most popular therapies in the world for their respective cancer and immune-disease indications, representing annual global revenue of more than $40 billion.

"After an exhaustive global review of potential partners, we selected the broad-scale inVentiv platform as an important differentiator for our program as this partnership spans both clinical and bioanalytical development as well as commercialization of our biosimilar assets.  inVentiv is able to take the scope of these agreements to a much broader level by working across the full development life cycle of each biosimilar and innovator product while preparing for a successful market launch. With their willingness to share in the risk/reward of our development programs, our firms are a perfect fit, both technically and culturally," said Oncobiologics Founder & CEO, Pankaj Mohan, Ph.D.

Ray Hill, President, inVentiv Health Clinical added, "We are thrilled to partner with Oncobi
'/>"/>

SOURCE Oncobiologics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Huahai and Oncobiologics Create Broad Biosimilars Partnership
2. Oncobiologics and Boston Oncology Team Up to Deliver Biosimilar Therapies for Cancer and Immune Disease to Middle East and North African Markets
3. inVentiv Health Partners With Medikly To Speed Clinical Trials By Accelerating The Recruitment Of Investigators
4. inVentiv Health Forms Strategic Alliance With Bell Medical Solutions, One Of Japans Top Clinical Research Organizations
5. PharmaNet/i3 Renamed inVentiv Health Clinical
6. inVentiv Health Strengthens Clinical Leadership Team
7. inVentiv Medical Management Forms Partnership with Vital Decisions
8. Frost & Sullivan Analyzes Emerging Opportunities for Stakeholders in the Transforming Healthcare Industry
9. Human Circuit Recognized as Industry Leader in Commercial Integrator Magazines Business Series as a Top 5 Healthcare Market Media Integrator for 2013
10. The Center for Ultrasound Research and Education (CURE) Receives Institutional Accreditation from the Accrediting Bureau of Health Education Schools
11. Indonesias Healthcare Reforms Create Opportunities But Also Present New Market Access Hurdles for the Multinational Pharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ISELIN, N.J. , July 1, 2015 /PRNewswire/ ... medical device company focused on non-invasive continuous glucose ... of its new and completely re-designed corporate website ... and intuitive access to Echo,s technology and enhances ... The new website better communicates to prospective ...
(Date:7/1/2015)... , July 1, 2015 Prismic Pharmaceuticals, ... and FDA-regulated medical foods, today announced the election of ... Simonetti to its Board of Directors. ... members, Peter Moriarty , Chairman and CEO of ... and Martin Simonetti have accepted our ...
(Date:7/1/2015)... July 1, 2015  Unilife Corporation (NASDAQ: UNIS ... of injectable drug delivery systems, announced today that its ... June 30, 2015. This amendment removed a covenant that ... cash receipts from customers during the six months ended ... any of the terms of the debt agreement as ...
Breaking Medicine Technology:Echo Therapeutics Announces New Website Launch 2Echo Therapeutics Announces New Website Launch 3Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3
... , WASHINGTON, Dec. 10 BioWorld Today ... Research and Manufacturers of America ( PhRMA ) that identifies 97 new ... conditions. , The report , which was released ahead of ... found that the 97 products in development include 23 vaccines and 54 ...
... , MILFORD, Mass., Dec. 10 ... that it is partnering with the NC BioNetwork Pharmaceutical ... NC, to educate and train students and workers in ... biopharmaceutical industry. The Pharmaceutical Center, which is a collaborative ...
Cached Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... technology and services, today announced that its fifth annual Smile for a Lifetime ... $80,000 for the non-profit organization. In addition to supporting S4L in its mission ...
(Date:7/1/2015)... ... 01, 2015 , ... The Collaborative for Children and Families (CCF) announced that ... will allow CCF to improve quality of care and save costs for the child ... to many changes in New York’s Medicaid system. Experts agree that children need thorough ...
(Date:7/1/2015)... ... 2015 , ... During the first week of June, Alamo ... Development) and Chuck Corso (Associate Sales Trainer) participated in the 44th Annual Life ... learning and development professionals from more than 300 life sciences companies around the ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... As if ... symptom found in a significant number of women: leg pain. Northeast Houston Vein Center ... Leg pain, a symptom of venous reflux disease, is underdiagnosed and often overlooked. Many ...
(Date:7/1/2015)... ... 2015 , ... RowdMap Inc. is a proud participant on ... Identifying the High-Cost Patient Population: Insights from the Health Care Transformation Task Force.” ... . , The Healthcare Transformation Task Force is a group of private sector ...
Breaking Medicine News(10 mins):Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... Professional Services Team Updates Television Infrastructure to Enable ... Technology EnhancementsSIOUX FALLS, S.D., May 19 LodgeNet ... LNET ) and the leading provider ... its LodgeNetRX(R) Interactive Patient Television System is now ...
... Needed to Focus Policy Actions at the Federal Level , ... ... Hepatitis Day , more than 200 viral hepatitis groups around the ... international and national support for improvements in prevention, diagnosis, treatment and ...
... 19 The Quigley Corporation, (Nasdaq: ... , today announced that it has uncovered ... Company,s Quigley Pharma, Inc. wholly-owned subsidiary COO, Dr. Richard ... documentary evidence of undisclosed payments from Karkus to Rosenbloom ...
... offers pet owners the keys to stress-free travel with your ... families hit the road for a getaway. For those ... a stress-free holiday and a trip filled with anxiety for ... ) is dedicated to providing pet owners the tools ...
... (NYSE: DGX ), the world,s leading provider of ... commenced a cash tender offer to purchase up to $200 ... Senior Notes due 2010 and 7.50% Senior Notes due 2011 ... offer are described in the Offer to Purchase dated May ...
... Hospital websites earn top honorsTROY, Mich., May 19 ... ), an information technology (IT) and Web products and ... honored for medical marketing excellence, earning two gold awards ... ) competition for its Web products and strategies supporting ...
Cached Medicine News:Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 3Health News:National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action 2Health News:National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action 3Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 2Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 3Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 4Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 5Health News:Top 10 Pet Travel Tips for Memorial Day 2Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 2Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 3Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 4Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 2Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 3
Fine abrasive for knife sharpening, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Standard knife with box, C profile...
... Cryostage freezing stage is a refrigerated design for ... primarily for use with the 8000 sledge microtome, ... microtomes. ,The refrigerated stage gives a large working ... is ridged to provide good adhesion between the ...
Medicine Products: